Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Inizio launches Intelligent Congress: Turning medical event investment into measurable impact

May 12, 2026 | Congress, Pharma, healthcare 

Inizio, the global commercialization partner to the health and life sciences industry, today announced the launch of Intelligent Congress – a connected, end-to-end solution designed to help pharma organizations maximize the value of congress investment and deliver measurable business impact.

- PMLiVE

Medical congresses remain one of the most critical data milestones in an asset’s development, providing valuable opportunities to translate scientific innovation into clinical practice. However, many organizations still approach congresses as standalone events, with fragmented planning across therapy area teams, limited alignment to overarching disease area objectives, and limited clarity on measuring success beyond immediate metrics. 

By operating as a single, integrated partner across the full data and congress lifecycle, Inizio helps clients navigate complexity, align stakeholders, and gain clearer confidence in the impact of their congress investments. Our strength lies in an unmatched vantage point – combining deep, cross-functional expertise with end-to-end visibility across the product lifecycle. 

Intelligent Congress is built on this foundation. Drawing on more than 30 years of experience across therapy areas, it unites strategy, experience design, delivery, and measurement into one cohesive model. This depth and breadth enable clients to move beyond fragmented, activity-based metrics and instead focus on what truly matters – meaningful shifts in HCP understanding, engagement, and behavior. 

Discover how Intelligent Congress can help you create more strategic, measurable, and impactful HCP engagement. Visit our congress page or connect with the Inizio team at booth 21157 during the ASCO® Annual Meeting 2026 to see Intelligent Congress in action. 

Read full article here.

This content was provided by Inizio

Company Details

- PMLiVE

Inizio

Email
Website

 Latest Content from  Inizio 

Webinar: The Brazil Conundrum

Conducting research in one of the world’s largest pharma markets

Webinar: Demand calibration: What’s inside the black box?

The process of demand calibration of preference share (down-weighting) is often a proprietary “black box” technique, which can mean that the client is unsure how the calibrated figure has been…

Free Thinking: Behavioural economics

Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?

Article: The Colombia Conundrum

Published in eye for pharma 30 January by Marc Yates

Ageing in China: The Implications for Healthcare

Published in eye for pharma 12 December by Marc Yates

5 years on from the Brazilian Generics Drugs Act, is there still an opportunity for branded originator drugs?

Published in Eye for Pharma 10 November by Marc Yates

Pegasus picks up “Specialist Consultancy of the Year” at the PRCA Awards 2014

Pegasus, the UK’s leading independent health communications consultancy, picked up the “Specialist Consultancy of the Year” award at the PRCA Awards 2014.

Pegasus supports unique theatrical performance as part of the 9th UK Dementia Congress

Brighton-based Pegasus, the UK’s leading independent health communications consultancy, is pleased to be supporting Naomi’s Flight – a bold and unique theatrical performance tour that highlights the impact of dementia…

It’s a hat trick for Pegasus!

Pegasus scoops the much-coveted “Consultancy of the Year” prize at the PR Week Awards 2014

Exploring MINT: Part 4 – Turkey

In the fourth and final of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in…